SBA Pre-Qualified Medical Device Company | Proprietary Robotics Systems | 22 Issued Patent Claims | 100% YOY Growth

Deal Pipe® presents a highly differentiated, SBA Pre-Qualified Medical Device Company operating at the forefront of automation-driven hair restoration. Founded in 2018, this business has built a defensible position within a rapidly expanding elective medical market by developing proprietary robotic systems that materially improve the speed, consistency, and economics of hair transplant procedures. Rather than incremental enhancement, the company’s technology replaces labor-intensive, technician-dependent workflows with intelligent, repeatable systems designed for scale, reliability, and superior clinical outcomes.

Business Model

The company generates revenue through the direct sale of high-ticket medical devices sold primarily to hair restoration clinics and physician-led practices. Average system sale prices exceed $110,000, with a typical sales cycle of one to two months from initial engagement to closing. Customers benefit from reduced consumable costs, predictable procedural workflows, and higher daily procedure capacity, which materially improves clinic-level profitability and drives strong buyer adoption. The company further differentiates itself by offering comprehensive onboarding, physician training, and operational support, creating long-term customer relationships that extend well beyond the initial sale.

SBA Pre-Qualification

This business has been reviewed for SBA acquisition eligibility and is pre-qualified for SBA financing, allowing qualified buyers to acquire the company with as little as 10% equity injection and the balance financed through an SBA-backed term loan amortized over up to 10 years. This financing structure significantly enhances cash-on-cash returns while preserving buyer liquidity for post-acquisition growth initiatives such as international expansion, product development, and sales team scaling. SBA eligibility reflects the company’s operating history, defensible revenue model, strong gross margins, and lender-friendly financial profile, making this opportunity particularly attractive to buyers seeking leveraged acquisition financing on favorable terms.

Operations

Manufacturing and operations are centralized in a dedicated facility with current capacity to produce multiple systems per day and clear pathways to scale output without structural changes to the business. The company maintains a lean but experienced internal team spanning research and development, technical operations, and customer-facing support, complemented by specialized third-party contractors where appropriate. This operating structure allows the business to maintain tight quality control, protect intellectual property, and respond quickly to market demand while avoiding unnecessary overhead.

Technology & Intellectual Property

A core strength of the business is its substantial intellectual property moat, supported by more than 22 issued patent claims granted by the USPTO. These protections cover critical elements of the company’s robotics, software, and procedural workflows, creating meaningful barriers to entry for competitors and long-term defensibility for a buyer. The company’s systems integrate advanced automation and precision-guided technology specifically engineered for follicular unit extraction, positioning the platform as a scalable foundation for future product iterations and adjacent medical applications.

Market Position

The business has achieved rapid penetration within the U.S. hair restoration market, capturing a significant market share by offering clinics a compelling alternative to legacy systems that are more expensive, less efficient, and operationally rigid. Its value-driven pricing, lower ongoing consumable costs, and hands-on client support have made the platform particularly attractive to growing practices seeking predictable outcomes without escalating operating complexity. This positioning has allowed the company to scale without reliance on aggressive advertising or discounting strategies.

Growth Opportunities

Significant upside remains for a new owner. The company is well-positioned to expand internationally, particularly into European and South American markets where demand for hair restoration procedures continues to accelerate. Additional opportunities include continued software development, next-generation device enhancements, and the introduction of complementary systems that leverage the existing IP and manufacturing infrastructure. These growth initiatives can be layered onto the current operation without rebuilding the core business.

Business Broker Takeaways

1. Category-Defining Medical Technology Asset: This business has moved beyond concept-stage innovation to commercial deployment, offering buyers a proven, patent-protected platform with real market share and clinical adoption.

2. High-Value Sales with Scalable Operations: Large average deal sizes, short sales cycles, and centralized production create a revenue model that scales efficiently without proportional increases in overhead.

3. SBA-Eligible with Significant Strategic Upside: SBA pre-qualification lowers acquisition friction while international expansion, product iteration, and software monetization provide clear paths to outsized returns.

Summary

This opportunity represents a rare chance to acquire a fast-scaling, IP-driven medical device business that has already solved the hardest challenges of product development, regulatory readiness, and market adoption. With meaningful U.S. market share, a defensible patent portfolio, production capacity in place, and SBA financing available, the company offers both stability and asymmetric growth potential. For buyers seeking exposure to the rapidly expanding elective medical market through a technology-led platform with real competitive advantages, this is an exceptional acquisition opportunity.

This Robotics Company is Represented by:

Deal Pipe

Tech-Enabled Business Brokers

WC 3905